Literature DB >> 4224603

Toxoplasmin sensitivity: subnormality and environment.

J S Robertson.   

Abstract

Mesh:

Year:  1966        PMID: 4224603      PMCID: PMC2134750          DOI: 10.1017/s0022172400040705

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


× No keyword cloud information.
  14 in total

1.  SPONTANEOUS ABORTION AND CHRONIC TOXOPLASMOSIS. REPORT OF A CASE, WITH ISOLATION OF THE PARASITE.

Authors:  J S REMINGTON; J W NEWELL; E CAVANAUGH
Journal:  Obstet Gynecol       Date:  1964-07       Impact factor: 7.661

2.  TOXOPLASMA SKIN- AND DYE-TEST SURVEYS OF SEVERELY SUBNORMAL PATIENTS IN LINCOLNSHIRE.

Authors:  J S ROBERTSON
Journal:  J Hyg (Lond)       Date:  1965-03

3.  [Toxoplasma infection and pregnancy. Histologic demonstration of the intrauterine route of infection].

Authors:  H WERNER; L SCHMIDTKE; G THOMASCHECK
Journal:  Klin Wochenschr       Date:  1963-01-15

4.  Congenital toxoplasmosis.

Authors:  O THALHAMMER
Journal:  Lancet       Date:  1962-01-06       Impact factor: 79.321

5.  Repeated congenital infection with toxoplasma gondii.

Authors:  H LANGER
Journal:  Obstet Gynecol       Date:  1963-03       Impact factor: 7.661

6.  The incidence of Toxoplasma antibodies in mental hospital patients.

Authors:  I COOK; E H DERRICK
Journal:  Australas Ann Med       Date:  1961-05

7.  Experimental transmission of Toxoplasma gondii.

Authors:  W M Hutchison
Journal:  Nature       Date:  1965-05-29       Impact factor: 49.962

8.  [Toxoplasmosis, the mother and the child].

Authors:  G Desmonts; J Couvreur; M S Ben Rachid
Journal:  Arch Fr Pediatr       Date:  1965-12

9.  Incidence of infective hepatitis followed by Down's syndrome nine months later.

Authors:  A Stoller; R D Collmann
Journal:  Lancet       Date:  1965-12-11       Impact factor: 79.321

10.  A SURVEY OF TOXOPLASMOSIS AMONG MENTALLY RETARDED CHILDREN.

Authors:  N A LABZOFFSKY; N A FISH; E GYULAI; F ROUGHLEY
Journal:  Can Med Assoc J       Date:  1965-05-08       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.